Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity
Top Cited Papers
- 15 October 2006
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 20 (20) , 2820-2832
- https://doi.org/10.1101/gad.1461206
Abstract
Target of rapamycin (TOR) is an evolutionally conserved protein kinase in eukaryotes and a central cell growth controller. TOR exists in two distinct complexes, termed TORC1 and TORC2. Mammalian TORC2 has recently been shown to possess kinase activity toward the C-terminal hydrophobic site of Akt/PKB. Here, we report that Sin1 is an essential component of TORC2 but not of TORC1, and functions similarly to Rictor, the defining member of TORC2, in complex formation and kinase activity. Knockdown of Sin1decreases Akt phosphorylation in both Drosophila and mammalian cells and diminishes Akt function in vivo. It also disrupts the interaction between Rictor and mTOR. Furthermore, Sin1 is required for TORC2 kinase activity in vitro. Disruption of the Rictor gene in mice results in embryonic lethality and ablates Akt phosphorylation. These data demonstrate that Sin1 together with Rictor are key components of mTORC2 and play an essential role in Akt phosphorylation and signaling.Keywords
This publication has 40 references indexed in Scilit:
- TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activityProceedings of the National Academy of Sciences, 2006
- Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 geneGene, 2004
- Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein KinaseJournal of Biological Chemistry, 2004
- Upstream and downstream of mTORGenes & Development, 2004
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivityNature, 2004
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteinsThe Journal of cell biology, 2004
- Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the CytoskeletonCurrent Biology, 2004
- Advances in protein kinase B signalling: AKTion on multiple frontsTrends in Biochemical Sciences, 2004
- PDK1, the master regulator of AGC kinase signal transductionSeminars in Cell & Developmental Biology, 2004
- Will mTOR inhibitors make it as cancer drugs?Cancer Cell, 2003